Abstract
Background
Endothelial function plays a key role in determining the clinical manifestations of atherosclerotic lesions. Elevated high‐sensitive C‐reactive protein (hsCRP) relates to long‐term prognosis of cardiovascular disease.
Hypothesis
We test the hypothesis that combined use of endothelial function and hsCRP could increase predictive value of future cardiovascular events.
Methods and Results
205 patients were followed up for a median period of 24 months. Endothelial function was assessed using brachial ultrasound to measure endothelium‐dependent flow‐mediated vasodilation (FMD). Cox regression analyses were conducted for the 205 subjects, with cardiovascular events being defined as myocardial infarction, hospitalization due to congestive heart failure, percutaneous coronary intervention, coronary artery bypass grafting, and ischemic stroke. Twenty nine (14%) developed cardiovascular events. Both FMD and hsCRP were significantly predictive of cardiovascular events (relative risk for patients with FMD < 3% as compared to those with FMD > 6%, 4.65, 95% confidence interval (CI): 1.30‐16.66, p = 0.018; relative risk for the highest as compared with the lowest tertile of hsCRP level, 3.59, 95% CI: 1.32‐9.74, p = 0.012, respectively). Further risk analysis was performed among four groups classified by FMD (FMD ≥ 6% or < 6%) and half percentile of hsCRP (hsCRP ≥ 1 or < 1 mg/dL). Relative risks for the FMD < 6%/hsCRP ≥ 1 mg/dL group compared to FMD ≥ 6%/hsCRP < 1 mg/dL group increased markedly to 12.598 (95% CI: 1.69 to 94.14, p = 0.014) for cardiovascular events.
Conclusions
Patients with suspected coronary artery disease may benefit from risk stratification based on both endothelium‐dependent FMD and hsCRP, since combined these two factors contribute significantly toward the incidence of cardiovascular events. Copyright © 2007 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (300.9 KB).
REFERENCES
- 1. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long‐term outcome of coronary heart disease. Circulation 2000; 101: 1899. [DOI] [PubMed] [Google Scholar]
- 2. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, et al.: New markers of inflammation and endothelial cell activation: Part I. Circulation 2003; 108: 1917. [DOI] [PubMed] [Google Scholar]
- 3. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, et al. Long‐term follow‐up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948. [DOI] [PubMed] [Google Scholar]
- 4. Chan NN, Colhoun HM, Vallance P: Cardiovascular risk factors as determinants of endothelium‐dependent and endothelium‐independent vascular reactivity in the general population. J Am Coll Cardiol 2001; 38: 1814. [DOI] [PubMed] [Google Scholar]
- 5. Schachinger V, Britten MB, Elsner M, Walter DH, Scharrer I, et al.: A positive family history of premature coronary artery disease with impaired endothelium‐dependent coronary blood flow regulation. Circulation 1999; 100: 1502. [DOI] [PubMed] [Google Scholar]
- 6. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, et al.: The prognostic value of C‐reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417. [DOI] [PubMed] [Google Scholar]
- 7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973. [DOI] [PubMed] [Google Scholar]
- 8. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, et al.: Elevated C‐reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000. [DOI] [PubMed] [Google Scholar]
- 9. Huang PH, Leu HB, Chen JW, Wu TC, Lu TM, et al.: Comparison of endothelial vasodilator function, inflammatory markers, and N‐terminal pro‐brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test. Heart 2006; 92: 609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Zeiher AM, Drexler H, Wollschlager H, Just H: Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984. [DOI] [PubMed] [Google Scholar]
- 11. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992; 326: 310. [DOI] [PubMed] [Google Scholar]
- 12. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, et al.: Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653. [DOI] [PubMed] [Google Scholar]
- 13. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, et al: Close relation of endothelial function in the human coronary and peripheral circulation. J Am Coll Cardiol 1995; 26: 1235. [DOI] [PubMed] [Google Scholar]
- 14. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE: Endothelium‐dependent dilation in the systemic arteries of asymptomatic subjects related to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468. [DOI] [PubMed] [Google Scholar]
- 15. Meredith IT, Anderson TJ, Uehata A, Yeung AC, Selwyn AP, et al.: Role of endothelium in ischemic coronary syndromes. Am J Cardiol 1993; 72: 27. [DOI] [PubMed] [Google Scholar]
- 16. Ridker PM, Hennekens CH, Buring JE, Rifai N: C‐reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836. [DOI] [PubMed] [Google Scholar]